相似文献
1
Combination of biomarkers for the detection of hepatocellular carcinoma.用于检测肝细胞癌的生物标志物组合
Ann Transl Med. 2020 Oct;8(20):1283. doi: 10.21037/atm-20-5798.
2
Hepatocellular carcinoma tumour markers: current role and expectations.肝细胞癌肿瘤标志物：当前作用与期望
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):843-53. doi: 10.1016/j.bpg.2014.07.018. Epub 2014 Aug 22.
3
Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.肿瘤标志物甲胎蛋白（AFP）和异常凝血酶原（PIVKA-II）在中国肝细胞癌患者中的诊断效能
Tumour Biol. 2017 Jun;39(6):1010428317705763. doi: 10.1177/1010428317705763.
4
Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma-What Do We Already Know.肝细胞癌和胆管癌的生物标志物与遗传标志物——我们已经了解了什么。
Cancers (Basel). 2022 Mar 15;14(6):1493. doi: 10.3390/cancers14061493.
5
Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌的循环预测性和诊断性生物标志物
World J Gastroenterol. 2016 Oct 7;22(37):8271-8282. doi: 10.3748/wjg.v22.i37.8271.
6
7
Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.与肝细胞癌相关的血清蛋白生物标志物及其检测
Analyst. 2016 Jan 7;141(1):36-44. doi: 10.1039/c5an01884f. Epub 2015 Nov 25.
8
The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.肠道微生物组作为一种非侵入性的预测性生物标志物，用于早期检测胰腺癌和肝细胞癌的潜力。
Eur Rev Med Pharmacol Sci. 2021 Dec;25(23):7275-7284. doi: 10.26355/eurrev_202112_27421.
9
Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma.用于肝细胞癌诊断和预后的基因组和蛋白质组生物标志物。
Biomark Med. 2007 Aug;1(2):273-84. doi: 10.2217/17520363.1.2.273.
10
Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma.联合检测 AFP、DCP 和 GPC3 的岩藻糖基化水平对肝细胞癌的早期诊断。
Int J Biol Markers. 2019 Mar;34(1):20-26. doi: 10.1177/1724600818812472. Epub 2019 Mar 10.
引用本文的文献
1
Machine Learning Approach and Bioinformatics Analysis Discovered Key Genomic Signatures for Hepatitis B Virus-Associated Hepatocyte Remodeling and Hepatocellular Carcinoma.机器学习方法与生物信息学分析发现了乙型肝炎病毒相关肝细胞重塑和肝细胞癌的关键基因组特征。
Cancer Inform. 2025 Apr 16;24:11769351251333847. doi: 10.1177/11769351251333847. eCollection 2025.
2
Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?血清软骨寡聚基质蛋白和高尔基体蛋白73：肝纤维化和肝细胞癌的新型诊断及预测工具？
Cancers (Basel). 2021 Jul 13;13(14):3510. doi: 10.3390/cancers13143510.
本文引用的文献
1
Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.高尔基体蛋白73与甲胎蛋白作为肝细胞癌早期诊断新生物标志物的比较
Int J Gen Med. 2020 May 18;13:193-200. doi: 10.2147/IJGM.S253622. eCollection 2020.
2
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.肝细胞癌的生物标志物：诊断、预后和治疗反应评估。
Cells. 2020 Jun 1;9(6):1370. doi: 10.3390/cells9061370.
3
The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.高尔基体蛋白73、磷脂酰肌醇蛋白聚糖-3和甲胎蛋白联合检测在肝细胞癌中的诊断价值：一项诊断性荟萃分析
Ann Transl Med. 2020 Apr;8(8):536. doi: 10.21037/atm.2020.02.89.
4
Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma.磷脂酰肌醇蛋白聚糖-3：肝细胞癌诊断与治疗的新靶点。
J Cancer. 2020 Feb 3;11(8):2008-2021. doi: 10.7150/jca.39972. eCollection 2020.
5
Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.血清标志物的动态变化及其在乙肝相关肝细胞癌各阶段早期诊断中的应用
Onco Targets Ther. 2020 Jan 28;13:827-840. doi: 10.2147/OTT.S229835. eCollection 2020.
6
Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.基于多种“组学”数据的生物标志物筛选用于肝细胞癌诊断。
World J Gastroenterol. 2019 Aug 14;25(30):4199-4212. doi: 10.3748/wjg.v25.i30.4199.
7
Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis.血清 Glypican 3 在肝细胞癌诊断中的性能：一项荟萃分析。
Ann Hepatol. 2019 Jan-Feb;18(1):58-67. doi: 10.5604/01.3001.0012.7863.
8
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.GALAD 评分系统在肝细胞癌检测中的应用与肝脏超声比较及 GALADUS 评分的提出。
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):531-538. doi: 10.1158/1055-9965.EPI-18-0281. Epub 2018 Nov 21.
9
Golgi protein 73 and its diagnostic value in liver diseases.高尔基体蛋白 73 及其在肝脏疾病中的诊断价值。
Cell Prolif. 2019 Mar;52(2):e12538. doi: 10.1111/cpr.12538. Epub 2018 Oct 19.
10
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.肝硬化患者肝细胞癌早期检测的监测成像和甲胎蛋白：一项荟萃分析。
Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6.
Zotero 插件